Estimating Residual Native Kidney Urea Clearance in Hemodialysis Patients With and Without 24-Hour Urine Volume-Reference-Cited by-同舟云学术

Estimating Residual Native Kidney Urea Clearance in Hemodialysis Patients With and Without 24-Hour Urine Volume

Published:2019-11 Issue:6 Volume:1 Page:376-382
ISSN:2590-0595
Container-title:Kidney Medicine
language:en
Short-container-title:Kidney Medicine

Author:

Chin Andrew I.,Sheth Vishwa,Kim Jeehyoung,Bang Heejung

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Nephrology,Internal Medicine

Reference19 articles.

1. Clinical benefit of preserving residual renal function in dialysis patients: an update for clinicians;Brener;Am J Med Sci,2010

2. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study;Shafi;Am J Kidney Dis,2010

3. CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study;Bargman;J Am Soc Nephrol,2001

4. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2;Termorshuizen;J Am Soc Nephrol,2004

5. Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients;Penne;Clin J Am Soc Nephrol,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Residual Kidney Function in Hemodialysis: Its Importance and Contribution to Improved Patient Outcomes;Toxins;2024-06-28

2. Fabrication of dialysis membrane from cotton Giza 86 cellulose di-acetate prepared using Ac2O and NiCl2 as a new catalyst;Scientific Reports;2023-02-08

3. Fabrication of dialysis membrane from cotton Giza 86 cellulose di-acetate prepared using Ac2O and NiCl2 as new catalyst;2022-11-28

4. Fibroblast growth factor 21 (FGF21) is a sensitive marker of osteoporosis in haemodialysis patients: a cross-sectional observational study;BMC Nephrology;2021-05-19

5. Renal replacement treatment initiation with twice-weekly versus thrice-weekly haemodialysis in patients with incident dialysis-dependent kidney disease: rationale and design of the TWOPLUS pilot clinical trial;BMJ Open;2021-05